Ticker
ADVMCompany Name
ADVERUM BIOTECHNOLOGIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 96.18M | $ 44.39M | $ 51.78M | $ 0 |
3/31/2025 | $ 137.65M | $ 51.14M | $ 86.52M | $ 0 |
12/31/2024 | $ 179.84M | $ 62.63M | $ 117.21M | $ 0 |
9/30/2024 | $ 234.38M | $ 94.83M | $ 139.55M | $ 0 |
6/30/2024 | $ 253.8M | $ 129.3M | $ 124.51M | $ 0 |
3/31/2024 | $ 267.83M | $ 151.58M | $ 116.24M | $ 0 |
12/31/2023 | $ 173.01M | $ 76.98M | $ 96.03M | $ 0 |
9/30/2023 | $ 196.77M | $ 108.02M | $ 88.75M | $ 0 |
6/30/2023 | $ 241.43M | $ 113.84M | $ 127.59M | $ 0 |
3/31/2023 | $ 275.58M | $ 70.06M | $ 205.52M | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: Assets [ $ 507.71M ] - Intangibles [ $ 0 ] - CashnEq [ $ 73.69M ]
(=) Core Assets [ $ 434.02M ]
Minimum
Jun 30, 2025
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.42B |
average | $ 805.95M |
median | $ 292.02M |
std | $ 1.06B |